SMPD1 and obesity disorder: In addition, Asm knockout or Asm inhibition was shown to have protective action during the lung inflammation and fibrosis [10], cystic fibrosis [11]–[12], obesity and associated glomerular injury [13], liver fibrogenesis [14] and renal fibrosis [15].